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Abstract An advanced water recycling demonstration plant was employed to investigate the effectiveness of a number 
of treatment technologies in the removal of some residuals of commonly prescribed pharmaceuticals as well as natural 
and synthetic hormones found in sewage.  
Analysis of targeted compounds was carried out by solid-phase extraction (SPE) and gas chromatography-mass 
spectrometry (GC-MS). Initial tests were undertaken to determine the background concentrations of the analytes 
during various stages of treatment. Subsequent tests, undertaken by spiking with standard solutions of the target 
compounds provided further information on the removal efficiencies of some selected treatment modules. The results 
of the study indicate that while ozonation, microfiltration and nanofiltration were partially effective; treatment by 
reverse osmosis was the most universally successful in the removal of the target residuals. 
While significantly more data is required for a full evaluation, this initial investigation suggests that reverse osmosis 
may be an effective means of removing a wider range of pharmaceutically active residuals and hormones from treated 
sewage.  
Keywords Microfiltration; nanofiltration; ozonation; reverse osmosis. 
 
Introduction 
Pharmaceuticals, hormones and their metabolites are rapidly emerging environmental contaminants 
of concern and many are only partially removed during conventional sewage treatment processes 
(Andreozzi et al., 2003; Huggett et al., 2003; Khan and Ongerth, 2003; Koutsouba et al., 2003). 
Factors contributing to the observed persistence of some compounds in secondary effluents include 
typically high water solubility and, in some cases, a resistance to aerobic biodegradation. 
The presence of pharmaceutical and hormonal residuals in sewage may influence how the water is 
used, recycled or discharged. Few studies have investigated the effectiveness of advanced water 
treatment technologies to remove these biologically active compounds. In this study, a unique 
opportunity allowed researchers to examine the efficacy of a range of advanced processes to remove 
some pharmaceutical and steroidal estrogen compounds from municipal sewage effluent. 
The Queensland Government, as a component of the Queensland Water Recycling Strategy, 
commissioned the construction of the Advanced Water Recycling Demonstration Plant (AWRDP) 
(Gibson and Apostolidis, 2001), which is shown in Figure 1. 
 
The plant consists of eight modules, each housing a different water treatment technology. For these 
studies, the influent to the AWRDP was taken from tertiary treated effluent from the nearby 
Brendale Wastewater Treatment Plant (Pine Rivers Shire Council). 
 
 
 
 
 
 
 
 
 
 
Figure 1 Photograph of the AWRDP 
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The modules of the AWRDP included lime clarification (LC), dissolved air flotation (DAF), dual 
media filtration (DMF), ozonation (O3), biological activated carbon filtration (BAC), microfiltration 
(MF), combined reverse-osmosis/nanofiltration (RO/NF) and UV-disinfection. Chlorine can be 
added if the use of the water requires the presence of a disinfection residual. Individual modules 
may be brought on-line or bypassed very quickly and simply. A schematic illustration of the 
AWRDP modules is presented in Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Schematic illustration of QLD AWRDP showing individual modules 
 
Pharmaceutical residues to be investigated were selected according their likelihood of being 
detected in the treated sewage (Khan and Ongerth, 2004) and their propensity for simultaneous 
extraction and analysis. The estrogenic hormones were selected as key estrogenic compounds in 
sewage. The chemical structures of the target analytes are shown in Figure 3.  
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Figure 3 Molecular structures of the estrogenic hormones and pharmaceutically active compounds (PhACs) 
 
Methods 
Analysis of Pharmaceuticals 
Duplicate 200 ml aliquots of each sample were measured into amber glass bottles. Samples were 
adjusted to pH 2 with dilute H2SO4 and processed immediately after collection. An acetonitrile 
solution (100 µl) of the surrogates, paracetamol-d4 (10.11 mg/l), salicylic acid-d6 (10.24 mg/l) and 
carbamazepine-d10 (10.09 mg/l), were added to each sample. SPE was performed on preconditioned 
Envi Chrom P cartridges at a flow rate no greater than 5 ml/min. The SPE tubes were then washed 
and then dried under nitrogen for at least 3 hours. They were eluted with 2ml of a 50:50 
acetonitrile/acetone mixture and evaporated to dryness under a constant stream of N2 at 30OC. All 
samples were derivatised by reaction with BSTFA (200 µl) in acetonitrile (200 µl) at 70OC for 1 
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hour. Samples were allowed to cool to room temperature before adding the internal standard, 
fluazifop-butyl (12.38 mg/l, 100 µl), and further acetonitrile (200 µl). All mass spectrometric 
measurements were acquired in selective ion monitoring (SIM) mode on a Hewlett-Packard 
HP5973 mass-selective detector combined with HP6890 gas chromatograph. Samples were 
chromatographed using a HP-5MS capillary column (5% Phenyl Methyl Siloxane, 30m x 0.25mm 
I.D. x 0.25µm film thickness). The carrier gas was helium at a constant flow rate of 1 ml/min. The 
oven temperature was held at 1000C for 3min after sample injection, and then ramped at 300C/min 
to 1700C and then at 10C/min to 2000C. Finally it was ramped at 300C/min to 2600C and held for 15 
min. A 1ml injection volume was administered by means of a HP6890 series autosampler using hot 
splitless injection. Ion dwell times were assigned to achieve a scan rate of 3-4 cycles per second 
within each SIM window. Analytes and their isotopic surrogates were each measured within a 
single SIM window, as were carbamazepine and phenytoin, which had similar retention times. 
Quantification was undertaken by calibration with the aid of the internal standard.  
 
Analysis of Hormones 
1 L samples were extracted on preconditioned 1g C18 cartridges under vacuum after the addition of 
estradiol-D4 as surrogate standard. The cartridges were dried under nitrogen and the extracts were 
eluted with acetonitrile. The eluents were then dried under vacuum. The estrogens were determined 
by GC-NICI-MS after a two-step derivatization with pentafluorobenzyl bromide followed by N-
trimethylsilylimidazole. This method was applied for the analysis of 17β-estradiol, estrone and 
ethinylestradiol in aqueous matrices using the d4-estrone as an internal standard. 
 
Treatment Plant Trials 
Initial investigations were carried out to determine “background” concentrations of the target 
compounds in the effluent from the various stages of the AWRDP. Background analyses were 
undertaken with the plant in two different configurations. The first configuration did not include the 
ozonation module. The second run was carried out with all modules including ozonation online. 
These two configurations were selected to optimise the likelihood of the detection of target 
compounds in the effluents of the DMF, O3, BAC, MF and RO/NF modules. All experiments 
described in this study were conducted with the RO/NF module loaded with both RO and NF 
subunits (Trisep X20 and XN40 membranes). These subunits were operated in parallel and samples 
were collected from each simultaneously. In addition to investigating the treatability of 
contaminants that were measurable in the various module influents, the small scale of the AWRDP 
permitted the undertaking of spiking experiments. By spiking measurable concentrations of the 
seven pharmaceutical compounds, it was possible to gain significantly more information on the 
behaviour of these compounds during the advanced treatment processes. Unfortunately, it was not 
practical to employ a continuous dosing method during these spiking tests. Therefore, an alternate 
method was used in which discrete doses were added to a feed reservoir every ten minutes over a 
one hour period. Two pharmaceutical & hormone spiking experiments were conducted. The first 
study incorporated both the microfiltration and RO/NF modules. The pharmaceuticals were spiked 
into the feed tank of the microfiltration module. Samples for analysis were taken from the 
microfiltration module (feed and permeate) and the RO/NF module (RO permeate, RO retentate, 
NF permeate, NF retentate). The second spiking experiment incorporated only the RO/NF module. 
The feed tank to the RO/NF module was spiked. Selected samples were then taken from the RO/NF 
feed, RO permeate, RO retentate, NF permeate, NF retentate. 
Results 
General Plant Performance in Terms of Bulk Organics Removal  
The results of the removal of three bulk organics, total organic carbon (TOC), chemical oxygen 
demand (COD) and chlorophyll (as a bulk indicator for algae) are presented in Figure 4. The 
processes are operated in series and hence show a steady increase in water quality as expected. 
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Figure 4 Retention of total organic carbon (TOC), chemical oxygen demand (COD) and chlorophyll by the different 
AWRDP processes 
 
Background Analysis 
The background concentrations of pharmaceutical residuals were measured in the various stages of 
the AWRDP in two plant configurations.  
In the first configuration, the ozone treatment module was offline and samples were collected from 
the effluents of DMF, BAC, MF and RO/NF modules. Salicylic acid was identified in the effluents 
of every tested module with DMF (0.33 µg/L), BAC (0.23 µg/L), MF (0.13 µg/L), RO permeate 
(0.16 µg/L), RO retentate (2.21 µg/L) and NF permeate (0.17 µg/L). Gemfibrozil (0.18 µg/L) was 
measured in the DMF effluent, however none of the other analytes were measurable in the DMF, 
BAC, MF, RO permeate or NF permeate samples. However, most were concentrated enough to be 
measurable in the RO retentate with ibuprofen (0.31 µg/L), gemfibrozil (0.86 µg/L), naproxen (0.70 
µg/L), ketoprofen (0.37 µg/L), estrone (0.092 µg/L), estradiol (0.0047 µg/L) and ethinylestradiol 
(0.0058 µg/L). Metronidazole and carbamazepine were not detectable in any of the samples. 
Once the ozone module was brought online, further background testing was undertaken on the 
effluents of the DMF module (immediately before ozone), the O3 module and the BAC module 
(immediately after ozone). In these tests, salicylic acid was observed in DMF (0.65 µg/L), O3 (0.26 
µg/L) and BAC (0.34 µg/L) effluents. All other analytes were below the limits of detection. 
 
Spiking Experiments 
Concentrations of pharmaceuticals in various stages of the AWRDP during spiking experiments are 
shown for two plant configurations. The first spiking run was conducted without ozonation online. 
Six stock solutions, each containing salicylic acid (3.2 mg), ibuprofen (1.6 mg), gemfibrozil (1.2 
mg), naproxen (0.8 mg) and ketoprofen (0.8 mg) in 200 ml of distilled water were prepared. These 
were dosed into the feed tank of the MF module at 10 minute intervals for one hour. Samples were 
collected after 30 minutes, 60 minutes and 75 minutes plant run time. Samples were collected from 
the feed water to the RO/NF module, both the permeate and retentate of a NF subunit, and the 
permeate from a RO subunit. Table 1 shows concentrations of each pharmaceutical residue in each 
sample. 
Table 1 Concentration of pharmaceuticals (µg/l) during Spiking Experiment 1 (ozone offline) 
 30 minutes 60 minutes 75 minutes 
Source 
RO/NF 
feed 
NF  
per 
NF  
ret 
RO  
per 
RO/NF 
feed 
NF 
per 
NF 
ret 
RO 
per 
RO/NF 
feed 
NF 
per 
NF 
ret 
RO 
per 
Salicylic Acid 2.33 19.89 11.42 0.25 4.79 3.80 10.38 n.d. n.d. 4.12 5.82 n.d. 
Ibuprofen 0.36 0.47 0.72 n.d. 0.68 0.14 1.95 n.d. 0.36 0.22 1.88 n.d. 
Gemfibrozil 0.76 0.43 1.08 n.d. 1.91 n.d. 5.31 n.d. 0.41 0.32 4.30 n.d. 
Naproxen 0.31 0.39 1.11 n.d. 0.53 n.d. 3.17 n.d. n.d. n.d. 2.02 n.d. 
Ketoprofen 0.22 n.d. 1.11 n.d. n.d. n.d. 2.30 n.d. n.d. n.d. 1.99 n.d. 
n.d.: not detected. 
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The second spiking experiment was conducted with the ozone treatment module online. Six stock 
solutions, each containing salicylic acid (1.3 mg), ibuprofen (2.2 mg), gemfibrozil (1.2 mg), 
naproxen (0.8 mg) and ketoprofen (1.1 mg) in 200 ml of distilled water were prepared. These were 
dosed into the feed tank of the RO/NF module at 10 minute intervals for one hour. Samples were 
collected at 45 minutes and 75 minutes after the beginning of the dosing period. Samples were 
collected from the feed and permeate water of the MF module, as well as the retentates and 
permeates of the RO and NF subunits of the RO/NF module. Table 2 shows the concentrations of 
each pharmaceutical residue in each sample. 
 
Table 2 Concentration of pharmaceuticals (µg/l) during Spiking Experiment 2 (ozone online) 
 45 minutes 75 minutes 
Source 
MF 
feed MF 
RO 
ret 
RO 
per 
NF 
ret 
NF 
per 
MF 
feed MF 
RO 
ret 
RO 
per 
NF 
ret 
NF 
per 
Salicylic Acid 6.87 3.07 1.44 n.d. 0.57 n.d. 0.56 n.d. n.d. n.d. n.d. n.d. 
Ibuprofen 1.87 0.79 1.04 n.d. 2.83 0.85 0.50 n.d. n.d. n.d. 0.96 n.d. 
Gemfibrozil 2.19 1.53 1.95 n.d. 4.65 0.28 0.70 n.d. 0.15 n.d. 3.36 n.d. 
Naproxen 1.65 0.63 1.32 n.d. 2.76 0.49 0.38 n.d. n.d. n.d. 0.65 n.d. 
Ketoprofen 0.86 0.29 0.82 n.d. 3.09 0.32 n.d. n.d. n.d. n.d. 0.04 n.d. 
n.d.: not detected. 
 
The hormone spiking tests were performed at identical intervals with hormone masses of 1.2 mg to 
allow for losses on the treatment system due to the likely adsorptive interactions as described by 
Schäfer et al. (2003) and Nghiem and Schäfer (2002). The results of these experiments are 
displayed graphically in Figure 4.  
 
Discussion 
These experiments were undertaken to determine the effectiveness of a range of advanced water 
recycling technologies for the removal of pharmaceuticals from treated sewage effluent. The 
technologies investigated included ozonation, microfiltration, nanofiltration and reverse-osmosis. 
The following discussion examines the results of the experiments in relation to the treatment 
technology and its suitability for use within a treatment train. 
 
Ozonation 
An OZAT CFS-2A ozone generator from Ozonia/Switzerland is used in the AWRDP. The 
generator has a production capacity of 80 g of ozone per hour and requires 2 m³ of air per hour to 
achieve this. The dosage rate is 17.5 mg O3/L and the contact time 15 minutes. 
Ozonation was only briefly examined in this study. The influent to the ozonation module was the 
effluent from the dual-media filtration module. By comparing the concentrations of pharmaceuticals 
in the ozonation influent to the ozonation effluent it was intended to determine the effectiveness of 
ozonation in the removal of these compounds. Since the influent is already quite highly treated 
wastewater, only salicylic acid was measurable. The result obtained indicates that salicylic acid was 
partially degraded from the influent (0.65 µg/l) to the effluent (0.26 µg/l) during ozonation. 
In other recent studies, ozonation has been shown to be variably effective in the abatement of 
various pharmaceutical and steroidal residues in sewage. Excellent degradation efficiencies have 
been reported observed for a range of compounds (Adams et al., 2002; Huber et al., 2003; Ternes et 
al., 2003). However, for some classes of drugs, most satisfactory results have been obtained with 
increased ozone concentration (Ternes et al., 2002) or the combined application of ozone/hydrogen 
peroxide (Zwiener and Frimmel, 2000). However, it should be noted that very little is known about 
the formation of by-products during ozone degradation of organics.  
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Microfiltration 
Initial testing of the wastewater indicated that salicylic acid was partially removed during 
microfiltration. The previous module (biological activated carbon) exhibited an effluent concen-
tration of 0.23 µg/l, while the microfiltration effluent was reduced to 0.13 µg/l.  
Spiking experiments were undertaken to further investigate the pharmaceutical removal efficiency 
of microfiltration (Table 2). During the spiking period, all of the analytes were observed in both the 
feed (influent) to the microfiltration unit and the effluent, however a partial reduction in concen-
tration was evident for all pharmaceuticals (Figure 5). Most of the pharmaceuticals were not 
measurable in samples collected from the microfiltration unit 25 minutes after the cessation of 
spiking (Table 2). 
 
 
 
 
 
 
 
Figure 5 Removal of pharmaceuticals by microfiltration during Spiking Experiment 1. 
 
The observed concentration reductions could be attributable to adsorption on the membrane rather 
than removal by size exclusion. This possibility could potentially be confirmed by the examination 
of removal over extended periods of operation, in which time the adsorptive capacity of the 
membrane for a particular compound may reach saturation. Previous studies have indicated that 
organics may be adsorbed, on initial spiking, to the microfiltration membrane. Once the influent 
concentration drops, the compounds then desorbs from the membrane (Chang et al., 2002). This 
process may have contributed to the observations described here. 
Another possible explanation is that the compounds may have been removed by size exclusion of 
larger particles on which the compounds may have been adsorbed. The accumulation of retained 
components in front of the membrane might also lead to a significant shift in separation behaviour, 
where the cake layer, rather than the membrane, determines the actual retention.  
 
Nanofiltration 
Spiking tests undertaken for the nanofiltration units gave some erratic results, where the membrane 
permeate concentration was greater than the measured concentration in the feed to the module 
(Table 1, salicylic acid, ibuprofen, naproxen). This was likely to be partially the result of variations 
caused by the stepwise (non-continuous) dosing regime and the time delay between sample 
collections, as well as the proximity to the detection limit. The retentate concentrations showed a 
definite increase which is a reflection of some degree of retention. 
Overall the retention of pharmaceuticals and hormones was lower than for RO which was expected 
from earlier laboratory trials where eight different nanofiltration and reverse osmosis membranes 
were compared. It should be noted that the nanofiltration membrane installed in this plant (XN40) 
has generally a very low retention of organic contaminants as confirmed in laboratory tests (Schäfer 
et al. 2003). Whether nanofiltration will be sufficient for the removal of such contaminants will 
depend on the levels to be achieved and the intended application of the treated water. It can be 
expected that retention for individual compounds varies strongly with the membrane type. This can 
be attributed to the similarity in membrane ‘pore’ size and the size of the contaminants. 
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The hormone retention by the membrane processes is shown in Figure 6. Feed concentrations are in 
a similar range as hormone concentrations found to date in Australian wastewaters (results not 
published). The permeates are very low confirming small scale results (Schäfer et al. 2003) where 
NF concentrations are slightly higher than RO permeates. Of interest, again, is the high 
concentration of all hormones in the RO concentrates. 
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Figure 6 Hormone concentrations in NF and RO feed, permeate and concentrate 
 
Reverse Osmosis 
The results of the spiking tests undertaken in this study indicate that the reverse osmosis process 
was the most effective in the removal of all of the tested pharmaceutical compounds (Table 1 and 
Table 2). Only in one case was any of the pharmaceuticals identified in the reverse osmosis 
permeate (salicylic acid, 0.25 µg/l) whereas they were regularly observed in the feed (Table 1) and 
the retentates (Table 2) at significant concentrations. Hormones appear to be more difficult to 
remove with traces of those compounds found in the RO permeates. This is in accordance with 
small laboratory-scale tests. The retention is highly membrane type dependent and further 
individual membrane testing will be required to fully characterise the retention mechanisms. 
The results obtained for the reverse osmosis analysis comply with other recently reported studies, in 
which pharmaceuticals have been almost universally removed from contaminated waters (Adams et 
al., 2002; Drewes et al., 2002; Heberer et al., 2002).  
 
Conclusions 
Of the advanced wastewater recycling technologies considered in this study, reverse-osmosis was 
able to demonstrate the most significant and consistent removal of the investigated pharmaceutical 
compounds and substantial removal of hormones. As such, reverse osmosis shows promising 
potential for the effective routine removal of a wider range of pharmaceutical residues from treated 
wastewaters, although some nanofiltration membranes can also achieve substantial removal. The 
results of this study will provide valuable information for the development of guidelines that will 
assist water authorities to carry out water recycling projects. 
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